Prospective comparison of liquid biopsy to standard of care tissue testing in metastatic, non-squamous, non-small cell lung cancer (NSCLC) patients (pts)

被引：0
|
作者：
Palmero, R. [1 ]
Taus, A. [2 ]
Majem Tarruella, M. [3 ]
Viteri, S. [4 ]
Costa, E. Carcereny [5 ]
Garde, J. [6 ,7 ]
Felip Font, E. [8 ]
Cassidy, C. [9 ]
Dix, D. [9 ]
Karachaliou, N. [4 ]
Rosell, R. [4 ,5 ]
机构：
[1] Catalan Inst Oncol, Lhospitalet De Llobregat, Spain
[2] Del Mar Hosp, Barcelona, Spain
[3] Santa Creu & St Pau Hosp, Barcelona, Spain
[4] Dexeus Univ Hosp, QuironSalud Grp, Inst Oncol Dr Rosell, Barcelona, Spain
[5] Germans Trias & Pujol Hlth Sci Inst & Hosp, Catalan Inst Oncol, Badalona, Spain
[6] Arnau de Vilanova Univ Hosp, Valencia, Spain
[7] Medica Scientia Innovat Res MEDSIR ARO, Barcelona, Spain
[8] Vall dHebron Univ Hosp, Barcelona, Spain
[9] Guardant Hlth Inc, Redwood City, CA USA
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1384TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [41] ENLARGE-Lung: A National, Prospective, Non-Interventional Study (NIS) of Nivolumab (Nivo) in Patients (pts) with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with Squamous and Non-Squamous Histology (Stage IIIB/IV) after Prior Chemotherapy
    Schulz, H.
    Sebastian, M.
    Groeschel, A.
    Guetz, S.
    Schuette, W.
    Mueller-Huesmann, H.
    von der Heyde, E.
    Schumann, C.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 109 - 109
  • [42] EFFICACY AND SAFETY OF PEMETREXED AS SECOND-LINE TREATMENT IN ELDERLY PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A RETROSPECTIVE ANALYSIS
    Passaro, A.
    Pochesci, A.
    Palleschi, M.
    Pellegrino, A.
    Fabbri, M. A.
    Urbano, F.
    Gentile, V.
    Manai, C.
    Pavese, I.
    Cortesi, E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S70 - S70
  • [43] Comparison of safety and efficacy between squamous and non-squamous non-small cell lung cancer (NSCLC) patients in phase II studies of DMXAA (ASA404)
    McKeage, M. J.
    Jameson, M. B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Predictors of biomarker testing among patients (pts) with metastatic non-small cell lung cancer (mNSCLC).
    Robert, Nicholas J.
    Chen, Liwei
    Espirito, Janet L.
    Karhade, Mandar
    Evangelist, Makenzi Colleen
    Neubauer, Marcus A.
    Bullock, Susie A.
    Walberg, Jennifer M.
    Coleman, Robert L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Liquid Biopsy in Non-Small Cell Lung Cancer
    Molina-Vila, Miguel A.
    Mayo-de-las-Casas, Clara
    Gimenez-Capitan, Ana
    Jordana-Ariza, Nuria
    Garzon, Monica
    Balada, Ariadna
    Villatoro, Sergi
    Teixido, Cristina
    Garcia-Pelaez, Beatriz
    Aguado, Cristina
    Jose Catalan, Maria
    Campos, Raquel
    Perez-Rosado, Ana
    Bertran-Alamillo, Jordi
    Martinez-Bueno, Alejandro
    Gil, Maria-de-los-Lianos
    Gonzalez-Cao, Maria
    Gonzalez, Xavier
    Morales-Espinosa, Daniela
    Viteri, Santiago
    Karachaliou, Niki
    Rosell, Rafael
    [J]. FRONTIERS IN MEDICINE, 2016, 3
  • [46] Real-World Biomarker Testing Patterns in Patients With Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in a US Community-Based Oncology Practice Setting
    Sireci, Anthony N.
    Krein, Peter M.
    Hess, Lisa M.
    Khan, Taha
    Willey, Joanne
    Ayars, Michael
    Deyoung, Kathryn
    Bhaskar, Sandhya
    Mumuney, Ganiat
    Coutinho, Anna
    [J]. CLINICAL LUNG CANCER, 2023, 24 (05) : 429 - 436
  • [47] A phase I study of ADXS-503 alone and in combination with pembrolizumab in subjects with metastatic squamous or non-squamous non-small cell lung cancer (NSCLC).
    Ramalingam, Suresh S.
    Stinchcombe, Tom
    Gerstner, Gregory James
    Haigentz, Missak
    Vangala, Surya
    Parsi, Megan
    Heyburn, John W.
    Kabala, Victor
    Prasad, Tuhina
    Gutierrez, Andres A.
    Goldman, Jonathan Wade
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] Is first-line pembrolizumab appropriate for all patients with metastatic non-squamous histology non-small cell lung cancer patients?
    Le, Laura
    van Dams, Ritchell
    Lee, Percy
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S327 - S330
  • [49] The CANOPY program: Canakinumab in patients (pts) with non-small cell lung cancer (NSCLC).
    Paz-Ares, Luis G.
    Garon, Edward B.
    Ardizzoni, Andrea
    Barlesi, Fabrice
    Cho, Byoung Chul
    Castro, Gilberto
    De Marchi, Pedro
    Felip, Enriqueta
    Goto, Yasushi
    Greystoke, Alastair
    Lu, Shun
    Lim, Darren Wan Teck
    Papadimitrakopoulou, Vassiliki
    Reck, Martin
    Solomon, Benjamin J.
    Spigel, David R.
    Tan, Daniel Shao-Weng
    Thomas, Michael
    Yang, James Chih-Hsin
    Johnson, Bruce E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Prognostic significance of aneuploidy in non-small cell lung cancer (NSCLC) patients (pts).
    Dziadziuszko, R
    Wegrzynowicz, E
    Kardas, I
    Limon, J
    Jassem, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 695S - 695S
12345